News and publishing service for psychedelic related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
Study Shows Psychedelic Use Could Lower Chances of Suffering Frequent Headaches
More People are Microdosing Psychedelics to Ease the Challenges of Parenting
DOD to Invest $9.8m into Psychedelic Studies Targeting Active-Duty Soldiers
Study Finds That the Mental Wellbeing Effects of Psilocybin Vary by Race
Study Suggests Psilocybin Can Treat Mild Concussions
PsychedelicNewsBreaks
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference
NRx Pharmaceuticals, Inc. (NRXP)
June 12, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine, Targets Expanding $750M Market
NRx Pharmaceuticals, Inc. (NRXP)
June 5, 2025
PsychedelicNewsBreaks – Rythmia Life Advancement Center Unveils Affiliate Program for Wellness Advocates
Rythmia Life Advancement Center
June 3, 2025
PsychedelicNewsBreaks – Lophora ApS Doses First Subjects in Phase 1 Trial of Psychedelic-Based CNS Drug LPH-5
Lophora ApS
May 28, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21
NRx Pharmaceuticals, Inc. (NRXP)
May 21, 2025
View More PsychedelicNewsBreaks
PsychedelicNewsWire Articles
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
NRx Pharmaceuticals, Inc. (NRXP)
June 12, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
NRx Pharmaceuticals, Inc. (NRXP)
June 5, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
NRx Pharmaceuticals, Inc. (NRXP)
May 28, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
NRx Pharmaceuticals, Inc. (NRXP)
May 23, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’
NRx Pharmaceuticals, Inc. (NRXP)
May 20, 2025
View All PsychedelicNewsWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000